| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 607427 | 85891 | IOFLUPANO (123I) ROTOP 74 MBQ/ML SOLUCION INYECTABLE EFG | IOFLUPANO (123I) ROTOP 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial x 2,5 ml | 74 MBq/ml | 45 | 1 | 34 | 1 vial x 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85891/85891_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85891/85891_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 34659 | 28969 | 2021-07-14 | 1 | 1 | 1 | 2021-07-14 | 2021-07-14 | 1 | 2022-09-12 | View Edit Delete | ||||||||||||
| 607466 | 85891 | IOFLUPANO (123I) ROTOP 74 MBQ/ML SOLUCION INYECTABLE EFG | IOFLUPANO (123I) ROTOP 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial x 5 ml | 74 MBq/ml | 45 | 1 | 34 | 1 vial x 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85891/85891_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85891/85891_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 34659 | 28969 | 2021-07-14 | 1 | 1 | 1 | 2021-07-14 | 2022-01-17 | 1 | 2022-09-12 | View Edit Delete | ||||||||||||
| 656615 | 59035 | BUDESONIDA PULMICTAN 200 microgramos/INHALACION SUSPENSION PARA INHALACION EN ENVASE A PRESION | BUDESONIDA PULMICTAN 200 microgramos/INHALACION SUSPENSION PARA INHALACION EN ENVASE A PRESION , 1 inhalador de 100 dosis | 200 microgramos/dosis | 6 | 100 | 30 | 1 inhalador de 100 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59035/59035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59035/59035_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2367 | 2367 | 1991-05-01 | 1 | 1 | 1 | 1991-05-01 | 2007-08-31 | 1 | 2012-01-02 | 684969 | View Edit Delete | |||||||||||
| 664450 | 95002004 | TAXOTERE 80 mg/4 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | TAXOTERE 80 mg/4 ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/95002004/95002004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/95002004/95002004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | 40842 | 2009-12-22 | 1 | 1 | 1 | 2009-12-22 | 2009-12-22 | 1 | 2011-06-13 | View Edit Delete | ||||||||||||
| 686770 | 59035 | BUDESONIDA PULMICTAN 200 microgramos/INHALACION SUSPENSION PARA INHALACION EN ENVASE A PRESION | BUDESONIDA PULMICTAN 200 microgramos/INHALACION SUSPENSION PARA INHALACION EN ENVASE A PRESION , 1 inhalador de 200 dosis | 200 microgramos/dosis | 6 | 200 | 30 | 1 inhalador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59035/59035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59035/59035_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2367 | 2367 | 1991-05-01 | 1 | 1 | 1 | 1991-05-01 | 2011-12-20 | 1 | 2013-09-30 | View Edit Delete | ||||||||||||
| 697800 | 77459 | ITRAGERM 50 MG CAPSULAS DURAS | ITRAGERM 50 MG CAPSULAS DURAS , 14 capsulas | 50 mg | 5 | 14 | 43 | 14, cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77459/77459_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77459/77459_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | 10266 | 2013-12-23 | 1 | 1 | 1 | 2013-12-23 | 2014-01-08 | 1 | 2014-06-17 | View Edit Delete | ||||||||||||
| 701154 | 77459 | ITRAGERM 50 MG CAPSULAS DURAS | ITRAGERM 50 MG CAPSULAS DURAS , 7 cápsulas | 50 mg | 5 | 7 | 43 | 7, cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77459/77459_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77459/77459_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | 10266 | 2013-12-23 | 1 | 1 | 1 | 2013-12-23 | 2014-01-08 | 1 | 2014-06-17 | View Edit Delete | ||||||||||||
| 704626 | 79326 | ETOPOSIDO ACCORD 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ETOPOSIDO ACCORD 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5 ml | 20 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79326/79326_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79326/79326_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2014-12-19 | 1 | 1 | 1 | 2014-12-19 | 2015-01-16 | 1 | 2015-08-26 | View Edit Delete | ||||||||||||
| 706437 | 79848 | BUPROPION SANDOZ 150 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | BUPROPION SANDOZ 150 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG , 30 comprimidos | 150 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79848/79848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79848/79848_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2015-06-01 | 1 | 1 | 1 | 2015-06-01 | 2015-06-12 | 1 | 2017-07-13 | View Edit Delete | ||||||||||||
| 707303 | 115997006 | PREGABALINA VIATRIS 25 MG CAPSULAS DURAS EFG | PREGABALINA VIATRIS 25 MG CAPSULAS DURAS EFG, 56 cápsulas | 25 mg | 5 | 56 | 43 | UNIDOSIS 56 capsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/115997006/115997006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/115997006/115997006_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-08-03 | 1 | 1 | 1 | 2015-08-03 | 2015-08-03 | 1 | 2015-10-13 | View Edit Delete | ||||||||||||
| 707328 | 115997020 | PREGABALINA VIATRIS 75 MG CAPSULAS DURAS EFG | PREGABALINA VIATRIS 75 MG CAPSULAS DURAS EFG, 56 cápsulas | 75 mg | 5 | 56 | 43 | UNIDOSIS 56 capsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/115997020/115997020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/115997020/115997020_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-08-03 | 1 | 1 | 1 | 2015-08-03 | 2015-08-03 | 1 | 2015-10-13 | View Edit Delete | ||||||||||||
| 707329 | 115997032 | PREGABALINA VIATRIS 150 MG CAPSULAS DURAS EFG | PREGABALINA VIATRIS 150 MG CAPSULAS DURAS EFG, 56 cápsulas | 150 mg | 5 | 56 | 43 | UNIDOSIS 56 capsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/115997032/115997032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/115997032/115997032_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-08-03 | 1 | 1 | 1 | 2015-08-03 | 2015-08-03 | 1 | 2015-10-13 | View Edit Delete | ||||||||||||
| 707336 | 115997048 | PREGABALINA VIATRIS 300 MG CAPSULAS DURAS EFG | PREGABALINA VIATRIS 300 MG CAPSULAS DURAS EFG, 56 cápsulas | 300 mg | 5 | 56 | 43 | UNIDOSIS 56 capsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/115997048/115997048_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/115997048/115997048_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2015-08-03 | 1 | 1 | 1 | 2015-08-03 | 2015-08-03 | 1 | 2015-10-13 | View Edit Delete | ||||||||||||
| 711118 | 1161096001 | LONSURF 15 MG/6,14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LONSURF 15 MG/6,14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 20 comprimidos | 15 mg/6,14 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161096001/1161096001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161096001/1161096001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12731 | 72805 | 2016-06-01 | 1 | 1 | 1 | 2016-06-02 | 2016-06-01 | 1 | 2016-12-02 | View Edit Delete | ||||||||||||
| 711119 | 1161096004 | LONSURF 20 MG/8,19 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LONSURF 20 MG/8,19 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 20 comprimidos | 20 mg/8,19 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161096004/1161096004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161096004/1161096004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12731 | 72805 | 2016-06-01 | 1 | 1 | 1 | 2016-06-02 | 2016-06-01 | 1 | 2016-12-02 | View Edit Delete | ||||||||||||
| 711120 | 1161096003 | LONSURF 15 MG/6,14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LONSURF 15 MG/6,14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 60 comprimidos | 15 mg/6,14 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161096003/1161096003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161096003/1161096003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12731 | 72805 | 2016-06-01 | 1 | 1 | 1 | 2016-06-02 | 2016-06-01 | 1 | 2016-12-02 | View Edit Delete | ||||||||||||
| 711121 | 1161096006 | LONSURF 20 MG/8,19 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LONSURF 20 MG/8,19 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 60 comprimidos | 20 mg/8,19 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161096006/1161096006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161096006/1161096006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12731 | 72805 | 2016-06-01 | 1 | 1 | 1 | 2016-06-02 | 2016-06-01 | 1 | 2016-12-02 | View Edit Delete | ||||||||||||
| 714176 | 81595 | BUPROPION CINFA 150 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | BUPROPION CINFA 150 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 150 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81595/81595_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81595/81595_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2017-01-13 | 1 | 1 | 1 | 2017-01-14 | 2017-01-13 | 1 | 2018-01-11 | View Edit Delete | ||||||||||||
| 718533 | 1171208002 | TRIMBOW 87 MICROGRAMOS/5 MICROGRAMOS/9 MICROGRAMOS SOLUCION PARA INHALACION EN ENVASE A PRESION | TRIMBOW 87 MICROGRAMOS/5 MICROGRAMOS/9 MICROGRAMOS SOLUCION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 pulsaciones | 87 microgramos/5 microgramos/9 microgramos | 34 | 120 | 30 | 1 inhalador de 120 pulsaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171208002/1171208002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171208002/1171208002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19683 | 26715 | 2017-08-13 | 1 | 1 | 1 | 2017-08-14 | 2017-08-13 | 1 | 2018-05-14 | View Edit Delete | ||||||||||||
| 718766 | 82361 | ENTECAVIR KERN PHARMA 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ENTECAVIR KERN PHARMA 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 0,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82361/82361_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82361/82361_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2017-08-30 | 1 | 1 | 1 | 2017-08-31 | 2017-08-30 | 1 | 2018-03-12 | View Edit Delete | ||||||||||||
| 721603 | 83075 | AMOROLFINA BLUEFISH 50 MG/ML BARNIZ DE UÑAS MEDICAMENTOSO | AMOROLFINA BLUEFISH 50 MG/ML BARNIZ DE UÑAS MEDICAMENTOSO, 1 frasco de 5 ml | 50 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83075/83075_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83075/83075_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20763 | 42274 | 2018-06-18 | 1 | 1 | 1 | 2018-06-18 | 2018-06-18 | 1 | 2018-06-20 | View Edit Delete | ||||||||||||
| 722187 | 83247 | SOLTEL 25 MICROGRAMOS/INHALACION SUSPENSION PARA INHALACION EN ENVASE A PRESION | SOLTEL 25 MICROGRAMOS/INHALACION SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 dosis | 25 microgramos/dosis | 86 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83247/83247_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83247/83247_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68210 | 23885 | 2019-03-26 | 1 | 1 | 1 | 2019-03-26 | 2019-03-26 | 1 | 2020-03-04 | View Edit Delete | ||||||||||||
| 722266 | 83260 | GEMCITABINA PRASFARMA 2.000 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | GEMCITABINA PRASFARMA 2.000 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 20 ml | 2.000 mg inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83260/83260_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83260/83260_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71367 | 71367 | 2018-07-04 | 1 | 1 | 1 | 2018-07-05 | 2018-07-04 | 1 | 2022-07-11 | View Edit Delete | ||||||||||||
| 722297 | 83263 | GEMCITABINA PRASFARMA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | GEMCITABINA PRASFARMA 200 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 2 ml | 200 mg inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83263/83263_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83263/83263_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71367 | 71367 | 2018-07-04 | 1 | 1 | 1 | 2018-07-05 | 2018-07-04 | 1 | 2022-07-11 | View Edit Delete | ||||||||||||
| 722298 | 83264 | GEMCITABINA PRASFARMA 1.000 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | GEMCITABINA PRASFARMA 1.000 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 1.000 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83264/83264_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83264/83264_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 71367 | 71367 | 2018-07-04 | 1 | 1 | 1 | 2018-07-05 | 2018-07-04 | 1 | 2022-07-11 | View Edit Delete | ||||||||||||
| 723773 | 1181274002 | TRYDONIS 87 MICROGRAMOS/5 MICROGRAMOS/9 MICROGRAMOS SOLUCION PARA INHALACION EN ENVASE A PRESION | TRYDONIS 87 MICROGRAMOS/5 MICROGRAMOS/9 MICROGRAMOS SOLUCION PARA INHALACION EN ENVASE A PRESION, 1 envase de 120 pulsaciones | 87 microgramos/5 microgramos/9 microgramos/dosis | 34 | 120 | 30 | 1 envase de 120 pulsaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181274002/1181274002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181274002/1181274002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19683 | 31982 | 2018-10-31 | 1 | 1 | 1 | 2018-11-01 | 2018-10-31 | 1 | 2022-11-15 | View Edit Delete | ||||||||||||
| 724469 | 83721 | EZETIMIBA/SIMVASTATINA VISO FARMACEUTICA 10 MG/20 MG COMPRIMIDOS EFG | EZETIMIBA/SIMVASTATINA VISO FARMACEUTICA 10 MG/20 MG COMPRIMIDOS EFG, 28 comprimidos | 10 mg/20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83721/83721_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83721/83721_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2018-12-28 | 1 | 1 | 1 | 2018-12-29 | 2018-12-28 | 1 | 2019-07-02 | View Edit Delete | ||||||||||||
| 724470 | 83722 | EZETIMIBA/SIMVASTATINA VISO FARMACEUTICA 10 MG/40 MG COMPRIMIDOS EFG | EZETIMIBA/SIMVASTATINA VISO FARMACEUTICA 10 MG /40 MG COMPRIMIDOS EFG, 28 comprimidos | 10 mg/40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83722/83722_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83722/83722_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2018-12-28 | 1 | 1 | 1 | 2018-12-29 | 2018-12-28 | 1 | 2019-07-02 | View Edit Delete | ||||||||||||
| 724749 | 83814 | EZETIMIBA/SIMVASTATINA TECNIGEN 10 MG/20 MG COMPRIMIDOS EFG | EZETIMIBA/SIMVASTATINA TECNIGEN 10 MG/20 MG COMPRIMIDOS EFG, 28 comprimidos | 20 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83814/83814_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83814/83814_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2019-02-08 | 1 | 1 | 1 | 2019-02-09 | 2019-02-08 | 1 | 2019-03-11 | View Edit Delete | ||||||||||||
| 724750 | 83815 | EZETIMIBA/SIMVASTATINA TECNIGEN 10 MG/40 MG COMPRIMIDOS EFG | EZETIMIBA/SIMVASTATINA TECNIGEN 10 MG/40 MG COMPRIMIDOS EFG, 28 comprimidos | 40 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83815/83815_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83815/83815_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2019-02-08 | 1 | 1 | 1 | 2019-02-09 | 2019-02-08 | 1 | 2019-03-11 | View Edit Delete | ||||||||||||
| 725138 | 83949 | QUETIAPINA QUALIGEN FARMA 200 MG COMPRIMIDOS DE LIBERACION PROLONGA EFG | QUETIAPINA QUALIGEN FARMA 200 MG COMPRIMIDOS DE LIBERACION PROLONGA EFG, 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83949/83949_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83949/83949_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2019-05-24 | 1 | 1 | 1 | 2019-05-24 | 2019-05-24 | 1 | 2022-04-12 | View Edit Delete | ||||||||||||
| 725145 | 83950 | QUETIAPINA QUALIGEN FARMA 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA QUALIGEN FARMA 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 300 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83950/83950_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83950/83950_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2019-05-24 | 1 | 1 | 1 | 2019-05-24 | 2019-05-24 | 1 | 2022-04-12 | View Edit Delete | ||||||||||||
| 725152 | 83951 | QUETIAPINA QUALIGEN FARMA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA QUALIGEN FARMA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83951/83951_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83951/83951_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2019-05-24 | 1 | 1 | 1 | 2019-05-24 | 2019-05-24 | 1 | 2022-04-12 | View Edit Delete | ||||||||||||
| 725160 | 83952 | QUETIAPINA QUALIGEN FARMA 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA QUALIGEN FARMA 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83952/83952_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83952/83952_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2019-05-24 | 1 | 1 | 1 | 2019-05-24 | 2019-05-24 | 1 | 2022-04-12 | View Edit Delete | ||||||||||||
| 725166 | 83953 | QUETIAPINA QUALIGEN FARMA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | QUETIAPINA QUALIGEN FARMA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 60 comprimidos | 150 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83953/83953_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83953/83953_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2019-05-24 | 1 | 1 | 1 | 2019-05-24 | 2019-05-24 | 1 | 2022-04-12 | View Edit Delete | ||||||||||||
| 725241 | 83987 | BUDESONIDA ALDO-UNION 100 MICROGRAMOS/PULSACION SUSPENSION PARA INHALACION EN ENVASE A PRESION | BUDESONIDA ALDO-UNION 100 MICROGRAMOS/PULSACION SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 200 dosis | 100 microgramos/dosis | 34 | 200 | 30 | 1 inhalador de 200 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83987/83987_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83987/83987_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | 16620 | 2019-04-02 | 1 | 1 | 1 | 2019-04-03 | 2019-04-02 | 1 | 2019-07-12 | View Edit Delete | ||||||||||||
| 725934 | 1181336001 | BUVIDAL 8 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 8 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.16 ml | 8 mg inyectable 0,16 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.16 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336001/1181336001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336001/1181336001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725935 | 1181336002 | BUVIDAL 16 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 16 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.32 ml | 16 mg inyectable 0,32 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.32 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336002/1181336002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336002/1181336002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725936 | 1181336003 | BUVIDAL 24 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 24 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA 1 jeringa precargada de 0.48 ml | 24 mg inyectable 0,48 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.48 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336003/1181336003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336003/1181336003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 725938 | 1181336004 | BUVIDAL 32 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA | BUVIDAL 32 MG SOLUCION INYECTABLE DE LIBERACION PROLONGADA, 1 jeringa precargada de 0.64 ml | 32 mg inyectable 0,64 ml | 33 | 1 | 61 | 1 jeringa precargada de 0.64 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181336004/1181336004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181336004/1181336004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 70748 | 30548 | 2019-07-08 | 1 | 1 | 1 | 2019-07-09 | 2019-07-08 | 1 | 2020-12-23 | Lista III | View Edit Delete | |||||||||||
| 726376 | 84351 | HERBION PASTILLAS PARA CHUPAR | HERBION PASTILLAS PARA CHUPAR, 16 pastillas | 35 mg | 5 | 16 | 29 | 16 pastillas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84351/84351_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84351/84351_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | 18017 | 2019-07-16 | 1 | 1 | 1 | 2019-07-17 | 2019-07-16 | 1 | 2019-10-31 | View Edit Delete | ||||||||||||
| 726401 | 1191372001 | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial de 2,5 ml | 74 MBq/ml inyectable 2,5 ml | 45 | 1 | 34 | 1 vial de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191372001/1191372001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191372001/1191372001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | 28969 | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-03-24 | View Edit Delete | ||||||||||||
| 726402 | 1191372001 | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial de 5 ml | 74 MBq/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191372001/1191372001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191372001/1191372001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | 28969 | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-03-24 | View Edit Delete | ||||||||||||
| 727061 | 1191389001 | EPIDYOLEX 100 MG/ML SOLUCION ORAL | EPIDYOLEX 100 MG/ML SOLUCION ORAL, 1 frasco de 100 ml | 100 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191389001/1191389001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191389001/1191389001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 35481 | 34449 | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2021-08-03 | View Edit Delete | ||||||||||||
| 727461 | 84688 | MINUSTOSAN 1,5 MG/ML JARABE EFG | MINUSTOSAN 1,5 MG/ML JARABE EFG, 1 frasco de 200 ml | 1,5 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84688/84688_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84688/84688_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28186 | 38124 | 2021-06-04 | 1 | 1 | 1 | 2021-06-04 | 2021-06-04 | 1 | 2022-09-13 | View Edit Delete | ||||||||||||
| 727673 | 84766 | BUPROPION TEVA 150 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | BUPROPION TEVA 150 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprmidos | 150 mg | 6 | 30 | 10 | 30 comprmidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84766/84766_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84766/84766_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2019-12-30 | 1 | 1 | 1 | 2019-12-31 | 2019-12-30 | 1 | 2020-07-14 | View Edit Delete | ||||||||||||
| 728960 | 85263 | DOLOMAX 40 MG/ML SOLUCION PARA PULVERIZACION CUTANEA | DOLOMAX 40 MG/ML SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 30 ml | 40 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85263/85263_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85263/85263_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42110 | 42110 | 2020-07-17 | 1 | 1 | 1 | 2020-07-18 | 2020-07-17 | 1 | 2024-02-07 | View Edit Delete | ||||||||||||
| 729297 | 1201448001 | CABAZITAXEL ACCORD 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | CABAZITAXEL ACCORD 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3 ml | 60 mg inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201448001/1201448001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201448001/1201448001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2020-10-20 | 1 | 1 | 1 | 2020-10-21 | 2020-10-20 | 1 | 2021-04-12 | View Edit Delete | ||||||||||||
| 730217 | 85714 | CABAZITAXEL EVER PHARMA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CABAZITAXEL EVER PHARMA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 6 ml | 60 mg inyectable 6 ml | 45 | 1 | 34 | 1 vial de 6 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85714/85714_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85714/85714_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23345 | 38524 | 2021-01-20 | 1 | 1 | 1 | 2021-01-21 | 2021-01-20 | 1 | 2021-08-12 | View Edit Delete | ||||||||||||
| 730243 | 109539007 | SAMSCA 7,5 MG COMPRIMIDOS | SAMSCA 7,5 MG COMPRIMIDOS, 10 x1 comprimido (dosis unitaria) | 7,5 mg | 5 | 10 | 10 | 10 x1 comprimido (dosis unitaria) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/109539007/109539007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/109539007/109539007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | 8454 | 2021-02-03 | 1 | 1 | 1 | 2021-02-04 | 2021-02-03 | 1 | 2021-06-10 | View Edit Delete | ||||||||||||
| 730420 | 1171208007 | TRIMBOW 172 microgramos/5 microgramos/9 microgramos SOLUCION PARA INHALACION EN ENVASE A PRESION | Trimbow 172 microgramos/5 microgramos/9 microgramos solución para inhalación en envase a presión, 120 dosis | 172 microgramos/5 microgramos/9 microgramos | 34 | 120 | 30 | 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171208007/1171208007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171208007/1171208007_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19683 | 26715 | 2021-02-24 | 1 | 1 | 1 | 2021-02-25 | 2021-02-24 | 1 | 2022-08-09 | View Edit Delete | ||||||||||||
| 730792 | 85908 | CABAZITAXEL ZENTIVA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG | CABAZITAXEL ZENTIVA 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG, 1 vial + 1 vial de disolvente | 60 mg inyectable 1,5 ml | 83 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85908/85908_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85908/85908_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | 67398 | 2021-11-02 | 1 | 1 | 1 | 2021-11-02 | 2021-11-02 | 1 | 2023-01-10 | View Edit Delete | ||||||||||||
| 730835 | 85924 | VAZOSTENON 20 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | VAZOSTENON 20 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 ampollas de 1 ml | 20 microgramos/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85924/85924_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85924/85924_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32394 | 32394 | 2021-04-19 | 1 | 1 | 1 | 2021-04-20 | 2021-04-19 | 1 | 2024-11-07 | View Edit Delete | ||||||||||||
| 731089 | 85993 | LEVOSIMENDAN ALTAN 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | LEVOSIMENDAN ALTAN 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 5 ml | 2,5 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85993/85993_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85993/85993_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31805 | 31805 | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-03-08 | View Edit Delete | ||||||||||||
| 731531 | 86171 | CARMUSTINA TEVA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARMUSTINA TEVA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 100 mg + 3 ml de disolvente | 100 mg | 83 | 1 | 34 | 1 vial de 100 mg + 3 ml de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86171/86171_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86171/86171_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2021-09-15 | 1 | 1 | 1 | 2021-09-15 | 2021-09-15 | 1 | 2021-11-14 | View Edit Delete | ||||||||||||
| 732216 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | 34173 | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 732217 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | 34173 | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 732473 | BE199692IP1 | PARIET 10 MG COMPRIMIDOS GASTRORRESISTENTES | PARIET 10 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE199692IP1/BE199692IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38151 | 23628 | 2025-07-03 | 1 | 1 | 1 | 2025-07-04 | 2025-07-03 | 1 | 2025-12-12 | View Edit Delete | ||||||||||||
| 732777 | 86548 | CICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | CICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 1 ml | 500 mg inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86548/86548_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86548/86548_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2022-02-07 | 1 | 1 | 1 | 2022-02-08 | 2022-02-07 | 1 | 2023-09-15 | View Edit Delete | ||||||||||||
| 732778 | 86548 | CICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | CICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 2 ml | 1.000 mg inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86548/86548_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86548/86548_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2022-02-07 | 1 | 1 | 1 | 2022-02-08 | 2022-02-07 | 1 | 2023-09-15 | View Edit Delete | ||||||||||||
| 732779 | 86548 | CICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | CICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 4 ml | 2.000 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86548/86548_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86548/86548_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | 27152 | 2022-02-07 | 1 | 1 | 1 | 2022-02-08 | 2022-02-07 | 1 | 2023-09-15 | View Edit Delete | ||||||||||||
| 733088 | 86667 | LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 5 ml | 2,5 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86667/86667_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86667/86667_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2022-07-08 | View Edit Delete | ||||||||||||
| 734014 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | 34173 | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 744939 | 87325 | LEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | LEVOSIMENDAN ZENTIVA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 5 ml | 2,5 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87325/87325_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87325/87325_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | 67398 | 2022-05-19 | 1 | 1 | 1 | 2022-05-20 | 2022-05-19 | 1 | 2024-11-15 | View Edit Delete | ||||||||||||
| 747144 | 87418 | VINORELBINA MEDAC 20 MG CAPSULAS BLANDAS EFG | VINORELBINA MEDAC 20 MG CAPSULAS BLANDAS EFG, 1 cápsula | 20 mg | 5 | 1 | 43 | 1 cápsula | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87418/87418_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87418/87418_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11137 | 10255 | 2022-05-23 | 1 | 1 | 1 | 2022-05-24 | 2022-05-23 | 1 | 2023-07-14 | View Edit Delete | ||||||||||||
| 747145 | 87419 | VINORELBINA MEDAC 30 MG CAPSULAS BLANDAS EFG | VINORELBINA MEDAC 30 MG CAPSULAS BLANDAS EFG, 1 cápsula | 30 mg | 5 | 1 | 43 | 1 cápsula | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87419/87419_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87419/87419_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11137 | 10255 | 2022-05-23 | 1 | 1 | 1 | 2022-05-24 | 2022-05-23 | 1 | 2023-07-14 | View Edit Delete | ||||||||||||
| 758092 | 1221678001 | LUPKYNIS 7,9 MG CAPSULAS BLANDAS | LUPKYNIS 7,9 MG CAPSULAS BLANDAS, 180 capsulas | 7,9 mg | 5 | 180 | 43 | 180 capsulas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221678001/1221678001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221678001/1221678001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29813 | 8454 | 2022-09-27 | 1 | 1 | 1 | 2022-09-28 | 2022-09-27 | 1 | 2023-11-02 | View Edit Delete | ||||||||||||
| 758156 | 88035 | CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN | CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial de 6 ml | 60 mg inyectable 6 ml | 45 | 1 | 34 | 1 vial de 6 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88035/88035_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88035/88035_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16041 | 34492 | 2022-08-17 | 1 | 1 | 1 | 2022-08-18 | 2022-08-17 | 1 | 2022-11-11 | View Edit Delete | ||||||||||||
| 761741 | 88525 | LUFORBEC 100 MICROGRAMOS/6 MICROGRAMOS/PULSACIÓN SOLUCIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN | LUFORBEC 100 MICROGRAMOS/6 MICROGRAMOS/PULSACIÓN SOLUCIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN, 1 inhalador de 120 dosis | 100 microgramos/6 microgramos/dos | 34 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88525/88525_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88525/88525_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 2023-04-25 | 1 | 1 | 1 | 2023-04-25 | 2023-04-25 | 1 | 2026-03-10 | View Edit Delete | ||||||||||||
| 763681 | 89127 | ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG | ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 2 ml | 0,44 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89127/89127_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89127/89127_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2023-10-31 | 1 | 1 | 1 | 2023-11-01 | 2023-10-31 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 763863 | 89176 | ERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFG | ERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFG, 1 vial de 2 ml | 0,44 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89176/89176_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89176/89176_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41367 | 44568 | 2023-12-01 | 1 | 1 | 1 | 2023-12-02 | 2023-12-01 | 1 | 2025-02-12 | View Edit Delete | ||||||||||||
| 763893 | 89191 | CARMUSTINA GLENMARK 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSION EFG | CARMUSTINA GLENMARK 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSION EFG, 1 vial polvo + 1 vial disolvente | 100 mg | 45 | 1 | 34 | 1 vial polvo + 1 vial disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89191/89191_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89191/89191_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2023-12-12 | 1 | 1 | 1 | 2023-12-13 | 2023-12-12 | 1 | 2024-06-10 | View Edit Delete | ||||||||||||
| 764049 | 89251 | ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG | ERIBULINA GLENMARK 0,44 MG/ML SOLUCIÓN INYECTABLE EFG, 1 vial de 2 ml | 0,44 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89251/89251_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89251/89251_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | 71079 | 2024-01-18 | 1 | 1 | 1 | 2024-01-19 | 2024-01-18 | 1 | 2024-11-14 | View Edit Delete | ||||||||||||
| 764529 | 89439 | BIBECFO 100 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION | BIBECFO 100 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 pulsaciones | 100 microgramos/6 microgramos/dosis | 34 | 120 | 30 | 1 inhalador de 120 pulsaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89439/89439_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89439/89439_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68210 | 23885 | 2024-03-12 | 1 | 1 | 1 | 2024-03-13 | 2024-03-12 | 1 | 2024-06-05 | View Edit Delete | ||||||||||||
| 764531 | 89440 | BIBECFO 200 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION | BIBECFO 200 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 pulsaciones | 200 microgramos/6 microgramos/dosis | 34 | 120 | 30 | 1 inhalador de 120 pulsaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89440/89440_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89440/89440_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68210 | 23885 | 2024-03-12 | 1 | 1 | 1 | 2024-03-13 | 2024-03-12 | 1 | 2024-06-05 | View Edit Delete | ||||||||||||
| 765387 | 1241819001 | ERIBULINA BAXTER 0,44 MG/ML SOLUCION INYECTABLE EFG | ERIBULINA BAXTER 0,44 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 2 ml | 0,44 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241819001/1241819001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241819001/1241819001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30180 | 7980 | 2024-07-15 | 1 | 1 | 1 | 2024-07-16 | 2024-07-15 | 1 | 2024-11-22 | View Edit Delete | ||||||||||||
| 765452 | 89728 | ERIBULINA ZENTIVA 0,44 MG/ML SOLUCION INYECTABLE EFG | ERIBULINA ZENTIVA 0,44 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 2 ml | 0,44 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89728/89728_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89728/89728_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | 67398 | 2024-07-22 | 1 | 1 | 1 | 2024-07-23 | 2024-07-22 | 1 | 2024-12-12 | View Edit Delete | ||||||||||||
| 765700 | 1241845022 | NILOTINIB ACCORD 200 MG CAPSULAS DURAS EFG | NILOTINIB ACCORD 200 MG CAPSULAS DURAS EFG, 112 cápsulas (4 envases x 28 cápsulas) | 200 mg | 5 | 112 | 43 | 112 cápsulas (4 envases x 28 cápsulas) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241845022/1241845022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241845022/1241845022_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2024-09-11 | 1 | 1 | 1 | 2024-09-12 | 2024-09-11 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 765701 | 1241845012 | NILOTINIB ACCORD 150 MG CAPSULAS DURAS EFG | NILOTINIB ACCORD 150 MG CAPSULAS DURAS EFG, 112 cápsulas (4 envases x 28 cápsulas) | 150 mg | 5 | 112 | 43 | 112 cápsulas (4 envases x 28 cápsulas) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241845012/1241845012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241845012/1241845012_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2024-09-11 | 1 | 1 | 1 | 2024-09-12 | 2024-09-11 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 765837 | 89838 | ERIBULINA EVER PHARMA 0,44 MG/ML SOLUCION INYECTABLE EFG | ERIBULINA EVER PHARMA 0,44 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 2 ml | 0,44 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89838/89838_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89838/89838_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23345 | 38524 | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 1 | 2024-12-13 | View Edit Delete | ||||||||||||
| 766169 | LT120001224001IP | AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS | AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT120001224001IP/LT120001224001IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | 17193 | 2024-11-11 | 1 | 1 | 1 | 2024-11-12 | 2024-11-11 | 1 | 2025-04-15 | View Edit Delete |